More than half of clinical trials analysed showed a high risk of bias. It was especially bad for drug and alcohol studies.
By James Stent
Science | 13 June 2022
Programme allowing the import and store of controversial drug for use against Covid brought to an end
By James Stent
Science | 30 May 2022
Survey of blood donors in March finds 98% of adults are either vaccinated, previously infected or both
By James Stent
Science | 27 May 2022
Here’s how we can keep the air healthy at home, at work and on public transport
By Gareth Kantor and Jennifer Stearns
Science | 18 May 2022
Far fewer people are dying but the disease remains extremely serious
By Nathan Geffen and Marcus Low
Science | 12 May 2022
We can eliminate this toxic pollutant - and make it profitable
Neil Stacey, James Fox, Klaus Moller, Diane Hildebrandt, David Glasser, and Celestin Sempuga
Science | 10 May 2022
The disease has been rare in rich countries for 50 years, and one reason is decent housing
By James Stent
Science | 10 May 2022
Vaccines against TB are much slower to develop than Covid ones
By James Stent
Science | 9 May 2022
An astonishingly expensive process for turning electricity into less electricity
Science | 9 May 2022
We need more inspectors, and we need the urgent implementation of the small-scale fisheries policy
Science | 4 May 2022
Evaluating the environmental footprint of electric cars
Science | 3 May 2022
Our government’s report card reads: “Must do better”
By Marc Mendelson and Moritz van Vuuren
Science | 10 February 2022
This is mainly due to antiretroviral treatment and condom promotion, but male medical circumcision and behaviour change after HIV diagnosis had a role too
Science | 9 February 2022
Part four in our series on antibiotic resistance
Science | 3 February 2022
I know of many cases where employers will not allow sick leave without employees having antibiotics to show for it
Science | 31 January 2022
Part two in a series on antibiotic resistance
Science | 27 January 2022